<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39445269</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Secondary Sclerosing Cholangitis (SSC): An Underrecognized Complication of Severe COVID-19 Pneumonitis.</ArticleTitle><Pagination><StartPage>e70003</StartPage><MedlinePgn>e70003</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70003</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.70003</ELocationID><Abstract><AbstractText>COVID-19-secondary sclerosing cholangitis (COVID-SSC) is a distinct subset of secondary sclerosing cholangitis in critically ill patients (SSC-CIP) that presents after COVID-19 infection with alkaline phosphatase predominant elevation of liver enzymes. COVID-SSC typically presents within three months of COVID-19 diagnosis and most commonly occurs following severe COVID-19 infection. COVID-SSC can have different clinical degrees of severity, ranging from clinically latent, as shown in this case report, to severely symptomatic, requiring a liver transplant or leading to patient death.  We present a case of COVID-SSC that presented in an asymptomatic patient months after severe COVID pneumonitis requiring prolonged intubation who was initially misdiagnosed with autoimmune hepatitis and found to have early cirrhosis at the time of diagnosis. The case presented was initially clinically silent and overlooked for months. In the aftermath of severe COVID-19 infection, COVID-SSC should be included in the differential diagnosis of unclear cholestasis, and general practitioners should have a high index of suspicion when encountering disproportionate elevation of alkaline phosphatase in patients with a history of COVID-19, in particular, those requiring intensive care unit (ICU) level cares.</AbstractText><CopyrightInformation>Copyright © 2024, Pogorelova et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pogorelova</LastName><ForeName>Mariya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Mayo Clinic, Rochester, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusztos</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine, Mayo Clinic, Rochester, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19 liver injury</Keyword><Keyword MajorTopicYN="N">covid-ssc</Keyword><Keyword MajorTopicYN="N">elevated alkaline phosphatase</Keyword><Keyword MajorTopicYN="N">secondary sclerosing cholangitis (ssc)</Keyword><Keyword MajorTopicYN="N">secondary sclerosing cholangitis in critically ill patients(ssc-cip)</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>4</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39445269</ArticleId><ArticleId IdType="pmc">PMC11498318</ArticleId><ArticleId IdType="doi">10.7759/cureus.70003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients. Leonhardt S, Veltzke-Schlieker W, Adler A, et al. Crit Care. 2015;19:131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407292</ArticleId><ArticleId IdType="pubmed">25886728</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID-19 cholangiopathy: a novel entity. Roth NC, Kim A, Vitkovski T, Xia J, Ramirez G, Bernstein D, Crawford JM. Am J Gastroenterol. 2021;116:1077–1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">33464757</ArticleId></ArticleIdList></Reference><Reference><Citation>Secondary sclerosing cholangitis following coronavirus disease 2019 (COVID-19): a multicenter retrospective study. Hunyady P, Streller L, Rüther DF, et al.  https://doi.org/10.1093/cid/ciac565 Clin Infect Dis. 2023;76:0–87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9278244</ArticleId><ArticleId IdType="pubmed">35809032</ArticleId></ArticleIdList></Reference><Reference><Citation>Secondary sclerosing cholangitis in critically ill patients: an underdiagnosed entity. Martins P, Verdelho Machado M. https://doi.org/10.1159/000501405. GE Port J Gastroenterol. 2020;27:103–114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7113589</ArticleId><ArticleId IdType="pubmed">32266307</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID-19 cholestasis: a case series and review of literature. Kulkarni AV, Khelgi A, Sekaran A, et al.  https://doi.org/https. J Clin Exp Hepatol. 2022;12:1580–1590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9187855</ArticleId><ArticleId IdType="pubmed">35719861</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. https://doi.org/10.1002/path.1570. J Pathol. 2004;203:631–637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication. Lui VC, Hui KP, Babu RO, et al.  https://doi.org/10.1038/s41598-022-09306-6. Sci Rep. 2022;12:5375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8965546</ArticleId><ArticleId IdType="pubmed">35354880</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-Covid-19 cholangiopathy-a new indication for liver transplantation: a case report. Durazo FA, Nicholas AA, Mahaffey JJ, et al.  https://doi.org/10.1016/j.transproceed.2021.03.007. Transplant Proc. 2021;53:1132–1137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953456</ArticleId><ArticleId IdType="pubmed">33846012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cholangiopathy after severe COVID-19: clinical features and prognostic implications. Faruqui S, Okoli FC, Olsen SK, et al.  http://10.14309/ajg.0000000000001264. Am J Gastroenterol. 2021;116:1414–1425.</Citation><ArticleIdList><ArticleId IdType="pubmed">33993134</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>